Jonathan P. DiVincenzo - 11 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, Pres, Central Labs & Intl
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Jonathan P. DiVincenzo
Issuer symbol
LH
Transactions as of
11 Feb 2024
Transactions value $
-$13,420
Form type
4
Filing time
13 Feb 2024, 12:15:04 UTC
Previous filing
08 Feb 2024
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +201 +5.35% 3.96K 11 Feb 2024 Direct F1
transaction LH Common Stock Tax liability -$13.4K -59 -1.49% $227.45 3.9K 12 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -201 -3.88% $0.00 4.98K 11 Feb 2024 Common Stock 201 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 11, 2024.
F4 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.